• Reading, Corneal Topography and Contact Lenses (opens in a new tab)

  Contact Lens & Visual Optics Laboratory Dr Nick Toalster

  A study of how eyelid pressure during reading changes the shape of the cornea. Rigid contact lenses largely prevent the effect.

  Read the publication – Reading, Corneal Topography and Contact Lenses (opens in a new tab)

• Drop Toxicity and At-Risk Ocular Surfaces (opens in a new tab)

  Pharma, March 2019 Dr Nick Toalster

  A practical guide to diagnosing and treating sore, red eyes caused by long-term glaucoma drops.

  Read the publication – Drop Toxicity and At-Risk Ocular Surfaces (opens in a new tab)

• Descemet’s Stripping Without Endothelial Keratoplasty (opens in a new tab)

  Current Opinion in Ophthalmology, 2019 Dr Nick Toalster

  A review of Descemet’s stripping only (DSO), a surgery for Fuchs’ dystrophy that avoids a donor graft. It covers success rates, clinical signs and the growing role of Rho-kinase inhibitor drops.

  Read the publication – Descemet’s Stripping Without Endothelial Keratoplasty (opens in a new tab)

• Temporo-Parietal Flap Incorporated into a Modified Osteo-Odonto Keratoprosthesis Protocol for Longevity of the Dental Lamina (opens in a new tab)

  Ophthalmic Plastic and Reconstructive Surgery, 2019 Dr Nick Toalster

  Describes a new flap technique that helps preserve the tooth-and-bone support of the “tooth-in-eye” artificial cornea used for severe corneal blindness.

  Read the publication – Temporo-Parietal Flap Incorporated into a Modified Osteo-Odonto Keratoprosthesis Protocol for Longevity of the Dental Lamina (opens in a new tab)

• Making Collaborative Care a Reality (opens in a new tab)

  mivision, Issue 154, March 2020 (Inez Hsing & Dr Nick Toalster) Dr Nick Toalster

  How optometrists and ophthalmologists can share care of glaucoma patients to catch disease earlier and keep monitoring patient-focused, illustrated with a real case.

  Read the publication – Making Collaborative Care a Reality (opens in a new tab)

• Descemet Stripping Only Supplemented with Topical Ripasudil for Fuchs Endothelial Dystrophy: 12-Month Outcomes of the Sydney Eye Hospital Study (opens in a new tab)

  Cornea, 2020 Dr Nick Toalster

  The Sydney Eye Hospital trial found that Descemet stripping with ripasudil eye drops cleared the cornea in 22 of 23 eyes. For selected Fuchs’ dystrophy patients it is a safe option that avoids a donor graft.

  Read the publication – Descemet Stripping Only Supplemented with Topical Ripasudil for Fuchs Endothelial Dystrophy: 12-Month Outcomes of the Sydney Eye Hospital Study (opens in a new tab)

• The Role of Diet, Nutrition and Exercise in Glaucoma Management (opens in a new tab)

  CPD module (Inez Hsing & Dr Nick Toalster) Dr Nick Toalster

  An evidence-based overview of how diet, supplements, exercise and general health affect glaucoma, with practical advice on discussing lifestyle with patients.

  Read the publication – The Role of Diet, Nutrition and Exercise in Glaucoma Management (opens in a new tab)

• Atypical Keratitis (opens in a new tab)

  Cataract & Refractive Surgery Today, August 2022 Dr Nick Toalster

  A step-by-step approach to corneal infections that don’t respond to standard antibiotic treatment.

  Read the publication – Atypical Keratitis (opens in a new tab)

• Clinicopathological Correlates of Ocular Surface Squamous Neoplasia (opens in a new tab)

  Ocular Oncology and Pathology, 2024;10:88-97 Dr Nick Toalster

  A study of 125 patients from Queensland that links the clinical features of ocular surface squamous neoplasia to its pathology grade. Treatment outcomes were generally favourable.

  Read the publication – Clinicopathological Correlates of Ocular Surface Squamous Neoplasia (opens in a new tab)

• Current and Emerging Strategies for the Manufacture, Implantation and Clinical Management of Corneal Tissue Allografts (opens in a new tab)

  Clinical and Experimental Optometry, December 2024 Dr Nick Toalster

  A review of how donor corneal tissue is stored, processed and transplanted. It covers organ culture, tailored surgical techniques and new cell therapies aimed at meeting growing global demand.

  Read the publication – Current and Emerging Strategies for the Manufacture, Implantation and Clinical Management of Corneal Tissue Allografts (opens in a new tab)

• Protecting the Cornea in Glaucoma: Why I Intervene Earlier with MIGS (opens in a new tab)

  mivision - mieducation CPD article (Dr Nicholas Toalster) Dr Nick Toalster

  Dr Toalster explains why he now recommends minimally invasive glaucoma surgery (MIGS) earlier. It reduces how many drops patients need for life and protects the cornea and ocular surface from the long-term effects of topical treatment.

  Read the publication – Protecting the Cornea in Glaucoma: Why I Intervene Earlier with MIGS (opens in a new tab)

• A 12-month prospective trial of inject and extend regimen for ranibizumab treatment of age-related macular degeneration (opens in a new tab)

  The Journal of Retinal and Vitreous Diseases. Dr Nick Toalster

  A prospective, multicentre trial of 45 patients evaluating a strictly applied inject and extend regimen of ranibizumab for neovascular age-related macular degeneration, showing significant vision gains maintained over 12 months with fewer visits than monthly monitoring protocols.

  Read the publication – A 12-month prospective trial of inject and extend regimen for ranibizumab treatment of age-related macular degeneration (opens in a new tab)

• Risk factors associated with XEN gel stent-related endophthalmitis (opens in a new tab)

  Clinical & Experimental Ophthalmology Dr Nick Toalster

  A case series from the Royal Victorian Eye and Ear Hospital reporting six cases of late-onset endophthalmitis following XEN gel stent implantation, highlighting stent exposure, bleb needling and mitomycin C use as likely risk factors.

  Read the publication – Risk factors associated with XEN gel stent-related endophthalmitis (opens in a new tab)